How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Chris Gibson built the pioneering AI biotech Recursion Pharmaceuticals on a foundation of bold promises. But after more than a decade at the helm, Gibson stepped down as CEO in November 2025. And his ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Viral python video: A massive Indian rock python was filmed climbing a tree, stunning viewers with its strength and agility. Rescue turns risky: In Dandeli, a snake expert was bitten by a 15-foot ...

Steve Nix is a member of the Society of American Foresters and a former forest resources analyst for the state of Alabama. Leaves are the food factories of the tree. Powered by sunlight, the green ...

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.